Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diclofenac 3% gel versus Solaraze versus vehicle in actinic keratosis
2011-003317-41Phase 3Completed
- Sponsor
- Dermapharm
- Start
- Sep 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of diclofenac in actinic keratosis (AK) (3 arms), sponsored by Dermapharm. Primary endpoint: Treatment success at final examination. Started Sep 2011; status: completed.
02
Drugs
diclofenac
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on 2011-003317-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-003317-41.